HONG KONG – A Chinese pharmaceutical company and its American partner have announced their plan to accelerate collaboration on the development of cancer drugs, with an eye on launching clinical trials in China soon. Read More
HONG KONG – The first human trial of a new vaccine based on virus-like particles (VLPs) suggests it is safe and effective against the rapidly emerging mosquito-borne chikungunya virus, researchers reported in the Aug. 15 early online edition of The Lancet. Read More
SHANGHAI – Newly minted Zai Lab Ltd., of Shanghai, has made its eagerly awaited debut announcement, obtaining global rights to two Sanofi SA preclinical compounds for chronic respiratory diseases. Read More
HONG KONG – Several major players in China's biopharmaceutical industry have released their second quarter and first-half 2014 financial results, with some companies having a better year than others so far. Read More
NEW DELHI – Indian biopharma company Vyome Biosciences raised almost $8 million in a second round of fundraising as part of a push to develop treatments for hard-to-treat skin conditions such as acne, persistent dandruff and bacterial and fungal skin infections. Read More
China YCT International Group Inc., of Shandong, China, said it signed a strategic cooperation agreement with Xi'an Putian Pharmacy LLP that will allow it to sell Huoliyuan capsules in 15 Chinese provinces. Terms were not disclosed. Read More
